October, 2020
HSG 2020: HD in Focus
Posted on October 29, 2020
The Huntington Study Group is a clinical research network focused exclusively on Huntington disease. Each year they host a conference that provides education…
Read MoreNovartis Receives FDA Orphan Drug Designation to Study Potential HD Treatment
Posted on October 22, 2020
This week the pharmaceutical company Novartis announced that they had received special status from the FDA, known as Orphan Drug Designation,…
Read MoreuniQure Trial Proceeds; Voyager Receives Regulatory Feedback
Posted on October 15, 2020
This week uniQure shared a press release stating that another two patients have entered their HD clinical trial. The drug, AMT-130, is an experimental gene therapy that…
Read MoreHDBuzz Covers Virtual EHDN Conference
Posted on October 8, 2020
The European Huntington’s Disease Network hosts a yearly Plenary meeting to discuss the latest in HD science and clinical trials,…
Read MoreHD Trialfinder: Study Updates
Posted on October 1, 2020
HDSA’s HD Trialfinder is an easy-to-use website that lists currently recruiting HD clinical trials in the United States and Canada. By answering some basic questions about…
Read More